Maria Chiara Barbanti

Maria Chiara Barbanti serves as an Oxford-BMS Research Fellow and DPhil student at the University of Oxford, affiliated with St Hugh's College and the MRC Weatherall Institute of Molecular Medicine (WIMM). Her research is conducted within the Vyas Group, which specializes in the Biology and Treatment of Human Myeloid Cancers.

Her scholarly focus spans hematology, oncology, and immunology with particular emphasis on stem cell transplantation dynamics, graft-versus-leukemia mechanisms, and microbiome-transplant interactions. Key research domains include:

• Identification of alloreactive antigens and T-cell responses in acute myeloid leukemia
• Microbiome-derived biomarkers for predicting acute GVHD and transplant outcomes
• Immune reconstitution and vaccination responses in bone marrow transplant recipients
• Clinical management of post-transplant lymphoproliferative disorders and HHV6 infections
• Optimizing infection control and continuity of care during healthcare crises

Analysis of her 15 most recent publications reveals a consistent clinical-translational trajectory centered on hematopoietic stem cell transplantation. Her work demonstrates methodological rigor through prospective cohort studies and single-center analyses, with recurring themes of microbiome-host interactions, immune monitoring in immunocompromised patients, and management of treatment complications in high-risk hematological malignancies. This body of work significantly contributes to prognostic modeling and therapeutic optimization in post-transplant care.

She operates within the Vyas Group at the WIMM, a research unit dedicated to advancing myeloid cancer biology through integrated laboratory and clinical investigations. The group maintains strong translational focus on developing novel immunotherapeutic approaches and refining transplantation protocols for leukemia treatment.